Please consider voicing your support for expanding Minnesota’s medical marijuana program!  On Wednesday, a medical marijuana review panel will meet to discuss the petitions to add opioid use disorders, Alzheimer’s disease, panic disorder, and psoriasis as qualifying conditions to the state’s medical cannabis program. What: Public meeting on adding conditions, including an opportunity for public comment When: Wednesday, October 24, from 1:00-4:00 p.m. Where: Room 300N, State Office Building, 100…

The Minnesota Medical Cannabis Program will be holding its second New Condition Review Panel Meeting on Tuesday, September 26. The panel will be reviewing five of the 10 petitioned conditions: liver disease, anxiety, obstructive sleep apnea, endocannabinoid deficiency, and dementia. It’s important to expand Minnesota’s qualifying conditions so that more patients have access to medical marijuana. This meeting is open to the public. If you cannot make the meeting, written comments can be sent to: [email protected] Here…